Thompson Davis & Co’s DexCom DXCM Stock Holding History

Thompson Davis & Co’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$8K	Sell	220 -160	-42%	-$4.96K	0.02%	488
2018 Q2	$9K	Buy	+380	New	+$8.06K	0.02%	438
2018 Q1	–	Sell	-9,548	Closed	-$137K	–	650
2017 Q4	$137K	Buy	+9,548	New	+$124K	0.32%	76
2016 Q4	–	Sell	-296	Closed	-$6K	–	1135
2016 Q3	$6K	Sell	296 -8	-3%	-$178	0.01%	786
2016 Q2	$6K	Buy	+304	New	+$5.18K	0.01%	748
2015 Q4	–	Sell	-6,000	Closed	-$129K	–	1140
2015 Q3	$129K	Sell	6,000 -1,000	-14%	-$22.3K	0.18%	133
2015 Q2	$140K	Sell	7,000 -1,000	-13%	-$17.6K	0.16%	146
2015 Q1	$125K	Sell	8,000 -500	-6%	-$7.55K	0.15%	146
2014 Q4	$117K	Sell	8,500 -3,500	-29%	-$42.8K	0.14%	156
2014 Q3	$120K	Sell	12,000 -1,500	-11%	-$15.3K	0.15%	137
2014 Q2	$134K	Buy	13,500 +12,500	+1,250%	+$111K	0.19%	128
2014 Q1	$10K	Hold	1,000	–	–	0.02%	484
2013 Q4	$9K	Buy	+1,000	New	+$7.91K	0.01%	465

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Thompson Davis & Co's DXCM Position: Q3 2018 in Review

Thompson Davis & Co reduced its DexCom (DXCM) stake by 42% in Q3 2018, selling an estimated $4.96K and leaving 220 shares worth $8K. The position accounts for 0.02% of the portfolio, ranked #488.

Thompson Davis & Co first reported a position in DXCM in Q4 2013 and has held it in 13 quarters since. The position peaked at $140K in Q2 2015. 364 funds tracked by Wall St. Rank hold DXCM as of Q3 2018.

Thompson Davis & Co held 220 shares of DexCom worth $8K as of Q3 2018.
Thompson Davis & Co sold 160 DexCom shares in Q3 2018, an estimated $4.96K.
DexCom made up 0.02% of Thompson Davis & Co's portfolio in Q3 2018, its #488 holding.
Thompson Davis & Co first reported a position in DexCom in Q4 2013 and has held it in 13 quarters since.
Thompson Davis & Co's DexCom position peaked at $140K in Q2 2015.
364 funds tracked by Wall St. Rank held DexCom as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.